Irbesartan + Hidroclorotiazida Bluepharma

Irbesartan, the active ingredient in Irbesartan + Hidroclorotiazida Bluepharma, is an angiotensin II receptor blocker combined with hydrochlorothiazide, a thiazide diuretic, presented as an oral tablet for systemic use. It is indicated for the treatment of hypertension in adult patients, helping to lower elevated blood pressure by targeting two complementary pathways.

GNH USA supplies Irbesartan + Hidroclorotiazida Bluepharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Irbesartan/Hydrochlorothiazide is used in the management of hypertension, acting on the renin‑angiotensin system and promoting diuresis. - Essential hypertension: lowers systolic and diastolic blood pressure. - Hypertension in patients with diabetes: improves blood pressure control while mitigating renal risk. - Hypertension with fluid retention: combines vasodilation and diuresis to achieve target pressures.

Like all antihypertensive agents, Irbesartan/Hydrochlorothiazide may cause adverse reactions.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Increased urination. - Mild electrolyte imbalance (e.g., low potassium). - Fatigue. - Gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe dehydration. - Significant electrolyte disturbances (hypokalemia, hyponatremia). - Acute renal impairment. - Angioedema or severe allergic reaction. - Marked hypotension. - Blood dyscrasias such as agranulocytosis.

Before initiating therapy, consider the following safety measures. - Pregnancy: contraindicated in the second and third trimesters (Category D). - Renal impairment: monitor kidney function and adjust therapy as needed. - Electrolyte monitoring: regularly check serum potassium and sodium levels. - Concomitant potassium‑sparing agents: avoid to prevent hyperkalemia. - Alcohol consumption: may enhance hypotensive effects. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Irbesartan/Hydrochlorothiazide can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Lithium: increased lithium concentrations may lead to toxicity. - ACE inhibitors or other ARBs: additive hypotensive effect and potential renal risk.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response and affect renal function. - CYP2C9 inhibitors (e.g., fluconazole): may raise irbesartan plasma levels.